Search by :
Last search:
1. In Vitro and In Vivo Testing of 177Lu-DOTA-Nimotuzumab, a Potential Radioimmunotherapeutical Agent of Cancersrn2. Increase of Oxidative Stress and Accumulation of α-Synuclein in Wistar Rat’s …